Changes in Health Status in the Ft. Devens Gulf War Veterans Cohort: 1997-2017.
Gulf War
epidemiology
health symptoms
longitudinal
neurotoxicant exposures
veterans
Journal
Neuroscience insights
ISSN: 2633-1055
Titre abrégé: Neurosci Insights
Pays: United States
ID NLM: 101760670
Informations de publication
Date de publication:
2020
2020
Historique:
received:
27
06
2020
accepted:
28
07
2020
entrez:
11
9
2020
pubmed:
12
9
2020
medline:
12
9
2020
Statut:
epublish
Résumé
Gulf War veterans (GWVs) were exposed to numerous neurotoxicants during deployment. Upon returning home, many reported a multitude of symptoms including fatigue, pain, gastrointestinal and respiratory issues, and neurological, cognitive, and mood complaints, collectively termed "Gulf War Illness (GWI)." Now, nearly 30 years post-war, many GWVs continue to suffer from these symptoms, in addition to health concerns associated with normal aging. While most research on GWVs has been cross-sectional, it is important to evaluate the progression and onset of new GWI symptoms longitudinally. The current study investigated the health of GWVs 25+ years after the war by resurveying the Ft. Devens Cohort and comparing their current health to their health reported 15 to 20 years earlier. The sample consists of 317 GWVs (~54 years old at the latest survey, 38 women) who responded to both surveys (1997-1998 and 2013-2017). Multivariable regression analyses were used to assess changes in GWI symptomatology and prevalence of medical conditions. The rates of 12 of 25 health symptoms increased significantly from the prior 1997-1998 survey. Anxiety, numbness in extremities, depressed mood, and joint pain had the greatest increase in endorsement. The rates of 7 of 16 medical conditions increased significantly from the prior 1997-1998 survey. High blood pressure, diabetes, and cancer had the greatest increase in prevalence. In summary, this study demonstrates that both symptoms and physician-diagnosed medical conditions associated with GW deployment/exposure increased in prevalence. For GWVs, focus by providers on the treatment of cognitive and mental health issues as well as cardiovascular and cerebrovascular risk factors is warranted. Targeting symptom alleviation would help improve the quality of life in these veterans until treatments addressing the entire illness become available.
Identifiants
pubmed: 32914090
doi: 10.1177/2633105520952675
pii: 10.1177_2633105520952675
pmc: PMC7444112
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2633105520952675Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Declaration of conflicting interests:The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The authors declare no conflicts of interest. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense, Department of Army, or the Department of Veteran Affairs. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office for this work.
Références
JAMA. 1998 Sep 16;280(11):981-8
pubmed: 9749480
Mil Med. 2018 Mar 1;183(3-4):e179-e185
pubmed: 29514346
J Occup Environ Med. 2018 May;60(5):e261-e267
pubmed: 29370011
Am J Ind Med. 2015 Dec;58(12):1246-54
pubmed: 26497120
Mil Med. 2017 Mar;182(3):1507-1508
pubmed: 28290920
J Diabetes Complications. 2009 Jul-Aug;23(4):283-96
pubmed: 18358748
West J Med. 2000 Feb;172(2):124-8
pubmed: 10693376
Neurotoxicology. 2006 Dec;27(6):931-9
pubmed: 16982099
J Occup Environ Med. 2020 Jan;62(1):4-10
pubmed: 31626064
Am J Ind Med. 2001 Jul;40(1):42-54
pubmed: 11439396
J Occup Environ Med. 2016 Jan;58(1):41-6
pubmed: 26716848
J Occup Environ Med. 2020 Sep;62(9):663-668
pubmed: 32890202
J Occup Environ Med. 2002 Mar;44(3):271-81
pubmed: 11911029
J Occup Environ Med. 2016 Aug;58(8):770-7
pubmed: 27500995
JAMA. 1999 Dec 1;282(21):2012-8
pubmed: 10591383
J Affect Disord. 2016 Jan 1;189:77-84
pubmed: 26409313
World J Diabetes. 2015 Oct 10;6(13):1246-58
pubmed: 26468341
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4295-300
pubmed: 18332428
Int J Epidemiol. 1998 Dec;27(6):1000-10
pubmed: 10024195
J Nerv Ment Dis. 1989 Jun;177(6):317-28
pubmed: 2723619
Neurotoxicology. 2007 Jul;28(4):761-9
pubmed: 17485118
Int J Environ Res Public Health. 2019 Mar 16;16(6):
pubmed: 30884809
Brain Sci. 2017 Jul 09;7(7):
pubmed: 28698487
J Head Trauma Rehabil. 2016 Sep-Oct;31(5):320-8
pubmed: 26291628
Am Heart J. 1999 Sep;138(3 Pt 2):211-9
pubmed: 10467215
Am J Epidemiol. 2000 Nov 15;152(10):992-1002
pubmed: 11092441
Am J Epidemiol. 2011 Oct 1;174(7):761-8
pubmed: 21795757
Neurology. 2011 Aug 2;77(5):461-8
pubmed: 21810696